美國(guó)LifeSpan Biosciences  www.lsbio.com
LifeSpan Biosciences公司是分子病理學(xué)行業(yè)的領(lǐng)頭軍，銷售抗體、免疫組化服務(wù)以及蛋白質(zhì)定位數(shù)據(jù)庫(kù)。1995年創(chuàng)立的LifeSpan Biosciences已開發(fā)了針對(duì)藥物標(biāo)靶主要種類的專有抗體，用以研究這些蛋白質(zhì)在人正常和患病組織中的表達(dá)。
LifeSpan Biosciences在高通量成像和癌癥鑒別軟件產(chǎn)品中也處于領(lǐng)先地位，正在開發(fā)用于在在臨診前期毒理學(xué)和癌癥診斷方面進(jìn)行病理學(xué)解讀的儀器和軟件。LifeSpan Biosciences的客戶包括位于美國(guó)、歐洲和日本的超過(guò)100家制藥公司。
LifeSpan Biosciences公司目前擁有多達(dá)37000種目錄抗體，其中近2000種抗體通過(guò)了免疫組化驗(yàn)證。LifeSpan Biosciences將繼續(xù)驗(yàn)證更多的免疫組化抗體。 

LifeSpan is the industry leader in molecular pathology. LifeSpan sells antibodies, immunohistochemistry services and localization databases. Founded in 1995, LifeSpan has developed proprietary antibodies to major classes of drug targets to study the expression of these proteins in normal and diseased human tissues.

LifeSpan is also a leader in high-throughput imaging and cancer recognition software and is developing instruments and software for pathology interpretation in preclinical toxicology and cancer diagnostics. LifeSpan's clients include more than 100 pharmaceutical companies in the United States, Europe, and Japan.